Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes [Video]

Key Takeaways

Ozempic can benefit patients with kidney disease as well as diabetesPatients with both conditions had lower risk of kidney and heart problemsThey also were less likely to die

FRIDAY, May 24, 2024 (HealthDay News) — Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found.

The drug significantly reduces the risk of severe kidney events, heart problems and death from any cause in patients who have both conditions, researchers found.

“These benefits signify a profound clinical impact saving kidneys, hearts and lives for patients with type 2 diabetes and chronic kidney disease,” said researcher Vlado Perkovic, provost of the University of New South Wales in Sydney, Australia. “Additionally, the reassuring safety findings further support the strong potential value of [Ozempic] in this population.”

Chronic kidney disease affects more than 800 million people worldwide, and is particularly common among people with type 2 diabetes, researchers …